Mochida Pharmaceutical Co., Ltd. (FRA:MFY)

Mochida Pharmaceutical Statistics

Total Valuation

FRA:MFY has a market cap or net worth of EUR 673.61 million. The enterprise value is 381.57 million.

Market Cap	673.61M
Enterprise Value	381.57M

Important Dates

The next estimated earnings date is Friday, February 6, 2026.

Earnings Date	Feb 6, 2026
Ex-Dividend Date	Sep 29, 2025

Share Statistics

Current Share Class	35.45M
Shares Outstanding	n/a
Shares Change (YoY)	-0.09%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	8.27%
Owned by Institutions (%)	22.10%
Float	23.15M

Valuation Ratios

The trailing PE ratio is 17.42.

PE Ratio	17.42
Forward PE	n/a
PS Ratio	1.07
PB Ratio	0.87
P/TBV Ratio	0.87
P/FCF Ratio	41.65
P/OCF Ratio	23.97
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.91, with an EV/FCF ratio of 23.59.

EV / Earnings	9.86
EV / Sales	0.63
EV / EBITDA	5.91
EV / EBIT	7.90
EV / FCF	23.59

Financial Position

The company has a current ratio of 4.73

Current Ratio	4.73
Quick Ratio	3.28
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	3,100.60

Financial Efficiency

Return on equity (ROE) is 5.08% and return on invested capital (ROIC) is 4.40%.

Return on Equity (ROE)	5.08%
Return on Assets (ROA)	3.59%
Return on Invested Capital (ROIC)	4.40%
Return on Capital Employed (ROCE)	6.66%
Revenue Per Employee	416,466
Profits Per Employee	25,649
Employee Count	1,508
Asset Turnover	0.67
Inventory Turnover	1.66

Taxes

In the past 12 months, FRA:MFY has paid 14.10 million in taxes.

Income Tax	14.10M
Effective Tax Rate	26.71%

Stock Price Statistics

The stock price has decreased by -7.92% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-7.92%
50-Day Moving Average	17.43
200-Day Moving Average	18.02
Relative Strength Index (RSI)	68.63
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:MFY had revenue of EUR 628.03 million and earned 38.68 million in profits. Earnings per share was 1.09.

Revenue	628.03M
Gross Profit	318.80M
Operating Income	53.57M
Pretax Income	52.78M
Net Income	38.68M
EBITDA	70.52M
EBIT	53.57M
Earnings Per Share (EPS)	1.09

Balance Sheet

The company has 303.61 million in cash and n/a in debt, giving a net cash position of 303.61 million.

Cash & Cash Equivalents	303.61M
Total Debt	n/a
Net Cash	303.61M
Net Cash Per Share	n/a
Equity (Book Value)	778.68M
Book Value Per Share	21.97
Working Capital	560.25M

Cash Flow

In the last 12 months, operating cash flow was 28.10 million and capital expenditures -11.93 million, giving a free cash flow of 16.17 million.

Operating Cash Flow	28.10M
Capital Expenditures	-11.93M
Free Cash Flow	16.17M
FCF Per Share	n/a

Margins

Gross margin is 50.76%, with operating and profit margins of 8.53% and 6.16%.

Gross Margin	50.76%
Operating Margin	8.53%
Pretax Margin	8.40%
Profit Margin	6.16%
EBITDA Margin	11.23%
EBIT Margin	8.53%
FCF Margin	2.58%

Dividends & Yields

This stock pays an annual dividend of 0.47, which amounts to a dividend yield of 2.55%.

Dividend Per Share	0.47
Dividend Yield	2.55%
Dividend Growth (YoY)	-3.47%
Years of Dividend Growth	n/a
Payout Ratio	42.21%
Buyback Yield	0.09%
Shareholder Yield	2.64%
Earnings Yield	5.74%
FCF Yield	2.40%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on March 27, 2019. It was a forward split with a ratio of 2.

Last Split Date	Mar 27, 2019
Split Type	Forward
Split Ratio	2

Scores

FRA:MFY has an Altman Z-Score of 4.78 and a Piotroski F-Score of 5.

Altman Z-Score	4.78
Piotroski F-Score	5